# Ritonavir-boosted Lopinavir Monotherapy

> **NCT01002898** · PHASE3 · COMPLETED · sponsor: **Bamrasnaradura Infectious Diseases Institute** · enrollment: 40 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** lopinavir/ritonavir soft gel capsule

## Key facts

- **NCT ID:** NCT01002898
- **Lead sponsor:** Bamrasnaradura Infectious Diseases Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002898, "Ritonavir-boosted Lopinavir Monotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01002898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*